NVIGEN X™ – Precision Medicine Biomarker Profiling

NVIGEN X™ Cancer Precision Profiling

NVIGEN X™ is enabled by the state-of-the-art molecularly engineered nanoparticles, MagVigen™ and MyQuVigen™, to efficiently capture and identify molecular information from proteins, cells and nucleic acids. We are developing NVIGEN X™ into accurate, automated and FDA approved clinical instruments, assays and reagent kits deploy-able at hundreds and thousands of hospitals, turning fatal cancers into manageable diseases.

Multiomics and Highly Sensitive Biomarking Profiling for Precision Curative Solution

From a single vial of whole blood sample, NVIGEN X™ applies the following streams of sample analysis:

  1. cfDNA Capture and Analysis
  2. NGS and Multiomics profiling
  3. Biomarker On-Beads ELISA Assay
  4. CTC Capture and Phenotype

Confirmative studies and further investigation with tissue or other biological samples and customized assays are also available.

Cancer, Aging & Nurodegenerative Diseases

  • Nucleic Acid/Protein/Cell Analyses
  • High Sensitivity and Accuracy
  • Workflow, Data and Cost Efficiency
  • Customizable Gene Panel


Cell Free DNA Technology

  • Low Abundance/Rare Targets
  • High Capture Yield
  • Optimal Quality for Molecular Dx
  • High Throughput
  • High Consistency and Reproducibility

Higher Yield of cfDNA Extracted with NVIGEN Extraction Kit vs. Q-ccf Extraction Kit

Complex Biomarker Research

  • High Sensitivity
  • Convenient Magnetic Workflow
  • Consistent Performance
  • Multiplexing Immunodiagnostics

PD-L1 on-bead-vs-on-plate

Sub-single Cell or Intracellular Molecules

  • Highly Sensitive and Specific CTC Captures
  • Customizable Cap-Antibody Cocktail
  • Integrated DNA/RNA/Protein Analyses

Circulating tumor cells isolated with MyQuVigen™ fluorescent magnetic nanoparticles from a whole blood sample

Case Study

Related Products